本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Avidity Biosciences, Inc.

46.58
-2.0000-4.12%
盘前46.45-0.1300-0.28%07:17 EDT
成交量:143.59万
成交额:6,785.81万
市值:59.93亿
市盈率:-13.06
高:49.11
开:48.56
低:46.37
收:48.58
52周最高:56.00
52周最低:21.51
股本:1.29亿
流通股本:9,981.53万
量比:0.70
换手率:1.44%
股息:- -
股息率:- -
每股收益(TTM):-3.5671
每股收益(LYR):-2.8885
净资产收益率:-37.76%
总资产收益率:-24.01%
市净率:5.02
市盈率(LYR):-16.13

数据加载中...

2025/03/25

重要事件披露

Form 8-K - Current report
2025/03/17

重要事件披露

Form 8-K - Current report
2025/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities